Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4574-4577

  Daniel, Thomas O ^a,b   Liu, Hua ^a   Morrow, Jason D ^a   Crews, Brenda C ^a   Marnett, Lawrence J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ICOSANOID; THROMBOXANE A2; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HYDRAZINE DERIVATIVE; ISOENZYME; MEMBRANE PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CORNEA; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; HUMAN; KIDNEY CIRCULATION; METABOLISM; MICROCIRCULATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CORNEA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROST; DINOPROSTONE; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; HUMANS; HYDRAZINES; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RENAL CIRCULATION; TETRADECANOYLPHORBOL ACETATE; THROMBOXANE A2;

EID: 0033567459     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Majima, M., Isono, M., Ikeda, Y., Hayashi, I., Hatanaka, K., Harada, Y., Katsumata, O., Yamashina, S., Katori, M., and Yamamoto, S. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75: 105-114, 1997.
2. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
3. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
4. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
5. Hla, T., and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 89: 7384-7388, 1992.
6. Creminon, C., Habib, A., Maclouf, J., Pradelles, P., Grassi, J., and Frobert, Y. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim. Biophys. Acta, 1214: 341-348, 1995.
7. Kage, K., Fujita, N., Oh-hara, T., Ogata, E., Fujita, T., and Tsuruo, T. Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone. Biochem. Biophys. Res. Commun., 254: 259-263, 1999.
8. Schmedtje, J. F. J., Ji, Y. S., Liu, W. L., DuBois, R. N., and Runge, M. S. Hypoxia induces cyclooxygenase-2 via the NF-KB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272: 601-608, 1997.
9. Kito, H., Yokoyama, C., Inoue, H., Tanabe, T., Nakajima, N., and Sumpio, B. E. Cyclooxygenase expression in bovine aortic endothelial cells exposed to cyclic strain. Endothelium, 6: 107-112, 1998.
10. Karim, S., Habib, A., Levy-Toledano, S., and Maclouf, J. Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J. Biol. Chem., 271: 12042-12048, 1996.
11. Blanco, A., Habib, A., Levy-Toledano, S., and Maclouf, J. Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem. J., 312: 419-423, 1995.
12. Busija, D. W., Thore, C., Beasley, T., and Bari, F. Induction of cyclooxygenase-2 following anoxic stress in piglet cerebral arteries. Microcirculation, 3: 379-386, 1996.
13. Matsumura, K., Cao, C., Ozaki, M., Morii, H., Nakadate, K., and Watanabe, Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J. Neurosci., 18: 6279-6289, 1998.
14. McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., and FitzGerald, G. A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA, 96: 272-277, 1999.
15. Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., and Morrow, J. D. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl Acad. Sci. USA, 94: 657-662, 1997.
16. Stein, E., Lane, A. A., Cerretti, D. P., Schoecklmann, H. O., Schroff, A. D., Van Etten, R. L., and Daniel, T. O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev., 12: 667-678, 1998.
17. Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E., Folkman, J., and D'Amato, R. J. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci., 37: 1625-1632, 1996.
18. Bustos, M., Coffman, T. M., Saadi, S., and Platt, J. L. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. J. Clin. Invest., 100: 1150-1158, 1997.
19. Ishizuka, T., Kawakami, M., Hidaka, T., Matsuki, Y., Takamizawa, M., Suzuki, K., Kurita, A., and Nakamura, H. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin. Exp. Immunol., 112: 464-470, 1998.
20. Armstrong, R. A., and Wilson, N. H. Aspects of the thromboxane receptor system. Gen. Pharmacol., 26: 463-472, 1995.
21. Krauss, A. H., Woodward, D. F., Burk, R. M., Gac, T. S., Gibson, L. L., Protzman, C. E., Abbass, F., Marshall, K., and Senior, J. Pharmacological evidence for thromboxane receptor heterogeneity: implications for the eye. J. Ocular Pharmacol. Ther., 13: 303-312, 1997.
22. Camacho, M., Lopez-Belmonte, J., and Vita, L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ. Res., 83: 353-365, 1998.
23. Honn, K. V. Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin. Exp. Metastasis, 1: 103-114, 1983.
24. Thomas, D. W., Mannon, R. B., Mannon, P. J., Latour, A., Oliver, J. A., Hoffman, M., Smithies, O., Koller, B. H., and Coffman, T. M. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J. Clin. Invest., 102: 1994-2001, 1998.
25. Bader, B. L., Raybum, H., Crowley, D., and Hynes, R. O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell, 95: 507-519, 1998.